Using the canine microbiome to bridge translation of cancer immunotherapy from pre-clinical murine models to human clinical trials

The microbiome has clearly been established as a cutting-edge field in tumor immunology and immunotherapy. Growing evidence supports the role of the microbiome in immune surveillance, self-tolerance, and response to immune checkpoint inhibitors such as anti PD-L1 and CTLA-4 blockade (1–6). Moreover,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleber, Kara T., Iranpur, Khurshid R., Perry, Lauren M., Cruz, Sylvia M., Razmara, Aryana M., Culp, William T. N., Kent, Michael S., Eisen, Jonathan A., Rebhun, Robert B., Canter, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412231/
https://www.ncbi.nlm.nih.gov/pubmed/36032113
http://dx.doi.org/10.3389/fimmu.2022.983344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412231/
https://www.ncbi.nlm.nih.gov/pubmed/36032113
http://dx.doi.org/10.3389/fimmu.2022.983344

Ejemplares similares